A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma.
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Umeclidinium/fluticasone furoate (Primary) ; Fluticasone furoate; Umeclidinium; Vilanterol/fluticasone furoate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2012 Additional trial locations (Argentina, Thailand) added as reported by ClinicalTrials.gov.
- 25 May 2012 Additional trial location (Russia) added as reported by ClinicalTrials.gov.